[go: up one dir, main page]

NL192387C - Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. - Google Patents

Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. Download PDF

Info

Publication number
NL192387C
NL192387C NL8503171A NL8503171A NL192387C NL 192387 C NL192387 C NL 192387C NL 8503171 A NL8503171 A NL 8503171A NL 8503171 A NL8503171 A NL 8503171A NL 192387 C NL192387 C NL 192387C
Authority
NL
Netherlands
Prior art keywords
formula
derivatives
ethanol
ethyl acetate
silibinine
Prior art date
Application number
NL8503171A
Other languages
English (en)
Dutch (nl)
Other versions
NL8503171A (nl
NL192387B (nl
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of NL8503171A publication Critical patent/NL8503171A/nl
Publication of NL192387B publication Critical patent/NL192387B/xx
Application granted granted Critical
Publication of NL192387C publication Critical patent/NL192387C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
NL8503171A 1984-11-22 1985-11-18 Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat. NL192387C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten
DE3442639 1984-11-22

Publications (3)

Publication Number Publication Date
NL8503171A NL8503171A (nl) 1986-06-16
NL192387B NL192387B (nl) 1997-03-03
NL192387C true NL192387C (nl) 1997-07-04

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8503171A NL192387C (nl) 1984-11-22 1985-11-18 Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.

Country Status (29)

Country Link
JP (1) JPS61143377A (de)
KR (1) KR870001020B1 (de)
AR (1) AR240931A1 (de)
AT (1) AT393268B (de)
BE (1) BE903693A (de)
CA (1) CA1337124C (de)
CH (1) CH659473A5 (de)
CS (1) CS273610B2 (de)
DD (1) DD259191A1 (de)
DE (1) DE3442639A1 (de)
DK (1) DK164865C (de)
EG (1) EG19424A (de)
ES (1) ES8609311A1 (de)
FI (1) FI84064C (de)
FR (1) FR2573427B1 (de)
GB (1) GB2167414B (de)
HU (1) HU195503B (de)
IE (1) IE58791B1 (de)
IT (1) IT1190426B (de)
LU (1) LU86163A1 (de)
MX (1) MX168415B (de)
NL (1) NL192387C (de)
NO (1) NO160205C (de)
PL (1) PL146890B1 (de)
PT (1) PT81532B (de)
SE (1) SE465676B (de)
SU (1) SU1436875A3 (de)
YU (1) YU43689B (de)
ZA (1) ZA858951B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
DK1856085T3 (en) * 2005-03-11 2015-10-05 Howard Florey Inst Pty Ltd FLAVONOID COMPOUNDS AND APPLICATIONS THEREOF
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
WO2009062737A1 (en) * 2007-11-15 2009-05-22 Madaus Gmbh Silibinin component for the treatment of hepatitis
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
US20150174213A1 (en) 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
GB8528226D0 (en) 1985-12-18
JPS61143377A (ja) 1986-07-01
FI854535A0 (fi) 1985-11-18
FR2573427A1 (fr) 1986-05-23
ES549116A0 (es) 1986-09-01
HU195503B (en) 1988-05-30
BE903693A (fr) 1986-05-22
YU43689B (en) 1989-10-31
NO160205B (no) 1988-12-12
SE8505487D0 (sv) 1985-11-20
CA1337124C (en) 1995-09-26
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
FI84064C (fi) 1991-10-10
DE3442639C2 (de) 1989-08-10
AR240931A1 (es) 1991-03-27
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
YU178685A (en) 1988-02-29
DK164865B (da) 1992-08-31
FI84064B (fi) 1991-06-28
ES8609311A1 (es) 1986-09-01
AR240931A2 (es) 1991-03-27
LU86163A1 (de) 1986-03-24
GB2167414A (en) 1986-05-29
EG19424A (en) 1995-02-28
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
JPH0432073B2 (de) 1992-05-28
IT1190426B (it) 1988-02-16
SU1436875A3 (ru) 1988-11-07
NL8503171A (nl) 1986-06-16
KR860004056A (ko) 1986-06-16
ZA858951B (en) 1986-08-27
DK537785A (da) 1986-05-23
NL192387B (nl) 1997-03-03
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
CH659473A5 (de) 1987-01-30
SE8505487L (sv) 1986-05-23
AT393268B (de) 1991-09-25
KR870001020B1 (ko) 1987-05-23
PT81532B (pt) 1987-11-11
ATA337185A (de) 1991-02-15
IE58791B1 (en) 1993-11-17
NO854655L (no) 1986-05-23
IT8522932A0 (it) 1985-11-21
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
MX168415B (es) 1993-05-24
DD259191A1 (de) 1988-08-17
PL256374A1 (en) 1986-12-02
GB2167414B (en) 1989-01-11
FI854535A (fi) 1986-05-23
NO160205C (no) 1989-03-22
IE852808L (en) 1986-05-22

Similar Documents

Publication Publication Date Title
EP0275224B1 (de) Phospholipidische Komplexe aus Vitis Vinifera-Extrakten, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen
JP3179494B2 (ja) プロブコールの可溶性類似体
NL192387C (nl) Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.
HU190774B (en) Process for preparing ether derivatives with pharmacological activity
KR0134376B1 (ko) 면역 억제제로서 유용한 4-퀴놀린 카르복실산 유도체
US3988446A (en) Glycerides with anti-inflammatory properties
US5202313A (en) Bilobalide derivatives, their applications and formulations containing them
CA2355776C (en) Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
US4046887A (en) Glycerides with anti-inflammatory properties
CA2031505C (en) Phospholipid derivative
EP1153010A1 (de) N-substituierte aminosäuren, pharmazeutische antioxidant-zusammensetzungen die diese enthalten und verfahren zu ihrer anwendung
JP3243879B2 (ja) 抗高脂血症剤
SI8511786A8 (sl) Postopek za pripravo derivatov silibinina
CH665642A5 (fr) Derives de l'aminomethyle-6 furo-(3,4-c)-pyridine, leur preparation et compositions therapeutiques en contenant.
JPS6233118A (ja) 抗炎症剤
WO2000049030A1 (fr) Derives de 5-fluorouridine et anticancereux renfermant ces derives comme principe actif
JPH0366685A (ja) イミダゾール誘導体及びそれを有効成分として含有する肝臓疾患治療薬

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MADAUS AKTIENGESELLSCHAFT

V1 Lapsed because of non-payment of the annual fee

Effective date: 20020601